| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.3 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |